Callus (or hard skin) Skin and Connective Tissue Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants were included if any of the following criteria applied: 1. They were aged 18 years and older 2. They had plantar callus 3. They had not been treated in the previous 6 weeks
Exclusion criteria
Exclusion criteria: Participants were excluded if any of the following criteria applied: 1. They had any skin disorders affecting the foot such as infections (e.g. Athlete’s foot), dermatitis, psoriasis, un-healed skin wounds, ulcers or blisters 2. They had a systematic disease including peripheral vascular disease or musculoskeletal disorders of the foot or ankle, rheumatoid arthritis or diabetes 3. They had allergies to any topical foot preparations with similar ingredients to those used in the trial treatments 4. They were unable to reach their feet to apply the products
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The most painful or the largest callus was selected as the index callus. The primary outcome was complete clearance of the index callus at 3 weeks after randomisation as determined by assessment by a HCPC registered podiatrist. ‘Clearance’ of calluses was defined as the restoration of normal skin upon close inspection, with the return of normal dermatoglyphics to the treated skin. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Improvement in hydration, elasticity, skin surface texture and callus size at 7 days, 14 days and 21 days 2. Change in quality of life (QoL) before and 3 weeks after treatment 3. Satisfaction with treatment at 3 weeks | — |
Countries
United Kingdom